Clinical Outcomes of Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions with a Novel Dynamic Coronary Roadmap System
International Heart Journal · 2023
DOI: 10.1536/ihj.23-213 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2023. Verfasst von Shojiro Hirano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Graduate School of Medicine. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Graduate School of Medicine.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University.
Zitieren
APA
Hirano, S., Yabe, T., Oka, Y., Kojima, Y., Aikawa, H., Noike, R., Amano, H., & Ikeda, T. (2023). Clinical Outcomes of Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions with a Novel Dynamic Coronary Roadmap System. International Heart Journal. https://doi.org/10.1536/ihj.23-213
Vancouver
Hirano S, Yabe T, Oka Y, Kojima Y, Aikawa H, Noike R, et al. Clinical Outcomes of Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions with a Novel Dynamic Coronary Roadmap System. International Heart Journal. 2023. doi:10.1536/ihj.23-213
BibTeX
@article{Hirano2023,
author = {Hirano, Shojiro and Yabe, Takayuki and Oka, Yosuke and Kojima, Yoshimasa and Aikawa, Hiroto and Noike, Ryota and Amano, Hideo and Ikeda, Takanori},
title = {Clinical Outcomes of Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions with a Novel Dynamic Coronary Roadmap System},
journal = {International Heart Journal},
year = {2023},
doi = {10.1536/ihj.23-213}
}
EUVIMED